After participant completes FLAG-IDA chemotherapy, participant may receive a stem cell transplant as part of participant's standard care. If participant is not eligible to receive a transplant, participant may continue to receive venetoclax alone for an additional year. This is called maintenance therapy. During Maintenance Therapy, participant will take venetoclax by mouth every day for up to 1 year.